Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous ...

The Treasury Department issued a rule that significantly waters down the number of businesses that must report information ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...

Digital accounting services have become a need, not a luxury. Digital transformation of accounting and reduction technologies ...

Swiss bank UBS scrapped references to establishing women in management roles and hiring employees from ethnic minority ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate ...

The requirement to report beneficial ownership information to the Financial Crimes Enforcement Network (FinCEN) is now not to be actively enforced or fined per recent announcements from the US ...

Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2024 and highlighted recent business progress.